Cesarean section may result in great trauma and postoperative pain. Besides incision pain,
uterine contraction pain is another source of postoperative pain after cesarean section. In
clinical practice, a large amount of uterine contraction agent is routinely applied after
cesarean section so as to promote involution of uterus and reduce postoperative hemorrhage,
which also causes great uterine contraction pain. Acute pain is the risk factor of chronic
pain, and may postpone the recovery from labour and influence the quality of life of
parturient. Though various analgesia modules have been attempted, more than 20% parturients
still experience severe postoperative pain, and pain management after cesarean section
remains a challenge to anesthesiologists.
This study aim to compare the effects of nalbuphine hydrochloride vs sufentanil citrate on
patient-controlled intravenous analgesia after cesarean section.
Oxycodone and Sufentanil for Analgesia in Hip Surgery
Enrolling by invitation
West China Hospital
We design this randomized controlled trial to compare the safety and efficacy of Oxycodone
and Sufentanil for postoperative patient-controlled analgesia in patients undergoing hip
surgery, with a view to finding the optimal postoperative analgesic regime with fewer adverse
reactions and promoting patients' rehabilitation.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.